Literature DB >> 1322895

Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta.

S X Lin1, F Yang, J Z Jin, R Breton, D W Zhu, V Luu-The, F Labrie.   

Abstract

Human placental 17 beta-hydroxysteroid dehydrogenase has been purified with a new rapid procedure based on fast protein liquid chromatography, yielding quantitatively a homogeneous preparation with high specific activity catalyzing the oxidation of 7.2 mumol of estradiol/min/mg of enzyme protein at 23 degrees C, pH 9.2. This preparation was shown to have a subunit mass of 34.5 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis while having a molecular mass of 68 kDa by both Superose-12 gel-filtration and native pore gradient gel electrophoresis. When 17 beta-hydroxysteroid dehydrogenase was expressed in HeLa cells or overproduced in insect cells using the baculovirus expression system, both from its cDNA encoding a protein of 34 kDa, the enzyme had the same migration in native and sodium dodecyl sulfate-gel electrophoresis as the purified one from human placenta and eluted from the Superose-12 column at the same elution volume. Moreover, all the above forms of this enzyme have similar specific activity. These results clearly demonstrate the identity of the three enzyme forms. The enzyme produced from the cDNA is expressed as a dimer, and its two subunits are identical. 17 beta-Hydroxysteroid dehydrogenase subunit identity is thus proved. The NH2-terminal analysis revealed a unique sequence of Ala-Arg-Thr-Val-Val-Leu-Ile for the purified enzyme from placenta, further confirming the above conclusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322895

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone.

Authors:  Ye Zhang; Ying-Ying Xu; Chuan-Bo Yao; Jin-Tao Li; Xiang-Ning Zhao; Hong-Bin Yang; Min Zhang; Miao Yin; Jing Chen; Qun-Ying Lei
Journal:  Autophagy       Date:  2017-02-22       Impact factor: 16.016

2.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

3.  Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.

Authors:  A Gangloff; A Garneau; Y W Huang; F Yang; S X Lin
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  Site-directed mutagenesis of the putative active site of human 17 beta-hydroxysteroid dehydrogenase type 1.

Authors:  T J Puranen; M H Poutanen; H E Peltoketo; P T Vihko; R K Vihko
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

5.  Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.

Authors:  M W Sawicki; M Erman; T Puranen; P Vihko; D Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

6.  Functional Silencing of HSD17B2 in Prostate Cancer Promotes Disease Progression.

Authors:  Xiaomei Gao; Charles Dai; Shengsong Huang; Jingjie Tang; Guoyuan Chen; Jianneng Li; Ziqi Zhu; Xuyou Zhu; Shuirong Zhou; Yuanyuan Gao; Zemin Hou; Zijun Fang; Chengdang Xu; Jianyang Wang; Denglong Wu; Nima Sharifi; Zhenfei Li
Journal:  Clin Cancer Res       Date:  2018-09-18       Impact factor: 12.531

7.  Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV.

Authors:  J Adamski; T Normand; F Leenders; D Monté; A Begue; D Stéhelin; P W Jungblut; Y de Launoit
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

Review 8.  Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants.

Authors:  Siba Shanak; Bashar Saad; Hilal Zaid
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-05       Impact factor: 2.629

9.  17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog.

Authors:  Emanuele M Gargano; Giuseppe Allegretta; Enrico Perspicace; Angelo Carotti; Chris Van Koppen; Martin Frotscher; Sandrine Marchais-Oberwinkler; Rolf W Hartmann
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 10.  Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.

Authors:  Erik Hilborn; Olle Stål; Agneta Jansson
Journal:  Oncotarget       Date:  2017-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.